How does tigecycline work against bacteria?
Tigecycline is a glycylcycline antibiotic. It suppresses bacterial growth by binding to the bacterial ribosome and blocking protein synthesis. Without new proteins, bacteria cannot grow or multiply effectively.
What happens to bacterial cells after tigecycline exposure?
By inhibiting protein production, tigecycline stops bacteria from building the proteins they need for growth, maintenance, and replication. This leads to reduced bacterial growth; depending on the organism and conditions, the effect can be bacteriostatic (growth stops) rather than directly killing cells.
Does tigecycline target all bacteria equally?
No. Its activity depends on the specific bacterial species and on resistance mechanisms. Some bacteria may have intrinsic or acquired resistance that reduces tigecycline’s ability to halt growth even when protein synthesis is inhibited. Resistance can include changes that reduce drug accumulation or affect how the ribosome interacts with the antibiotic.
What determines whether bacterial growth is strongly inhibited?
The degree of growth inhibition depends on factors such as:
- the bacterial species and strain,
- the bacterial growth state (for example, actively dividing vs slower-growing conditions),
- the local drug concentration achieved at the infection site, and
- resistance mechanisms present in that strain.
Where do patients and clinicians typically see tigecycline used?
Tigecycline is used for certain complicated bacterial infections in clinical settings, where clinicians choose it when the suspected or confirmed bacteria are susceptible and when other treatment options may be less appropriate.